In June 2025, the first five health apps were rated and recommended by the Board for Health Apps in Denmark. The rated apps concern endocrine, orthopedics, neurology and neurosurgery, mental health, and primary care fields. The Board will continuously evaluate new apps; the list will be expanded as new apps are recommended.

In June 2025, the Skåne University Hospital (HTA South) is working on health technology assessments in several areas, including diagnostic imaging, e-health, in-vitro diagnostics, men’s health and neurology.

On June 17, 2025, the UK National Screening Committee (UK NSC) opened a public consultation on the updated evidence review regarding population screening for dementia in adults. The 2025 review concludes that there is still insufficient evidence to support the introduction of a national screening programme. Stakeholders are invited to submit comments by September 9, 2025.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Sustainability Publications Digest. In a recent publication, Kloevekorn et al. conducted a qualitative systematic review to analyze direct sources of carbon emissions in hospital surgical care, using the Congruence Model as a framework. The authors found that major emission sources include anesthetic gases, sterilization practices, and ingrained workplace behaviors, while sustainability efforts are primarily linked to waste policies. The study highlights the value of the Congruence Model for uncovering challenges in decarbonizing surgical care.

On June 18, 2025, a new version of the Nomenclature of Medical Biology Procedures (NABM 98) was released. Seven new codes were introduced.

On June 16, 2025, the Decision Forum for the "New Methods" framework made a favorable coverage decision for leadless pacemakers (Micra™) to treat patients with atrial fibrillation and bradycardia in specific clinical indications.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Jaksa et al. conducted a targeted review of health technology reassessments across six international HTA agencies to examine the use of real-world evidence (RWE). The analysis of 40 recent reassessments found that 55% incorporated RWE, primarily drawing on registry data to address clinical uncertainties. However, RWE use did not alter patient access outcomes, and no de novo comparative RWE studies were identified, highlighting the need for greater alignment between agencies and sponsors on evidence needs and study feasibility.

The Danish Health Data Authority quarterly updates the Health Care Classification System (SKS). The latest version was published in mid-June 2025 to come into force on July 1, 2025. Among other changes, seventy-eight new procedure codes were introduced concerning dermatology, endoscopy, ENT, interventional radiology, obstetrics and gynecology, orthopedics, spine, surgical procedures, and some other fields.

MTRC is pleased to announce the release of its latest White Paper: “Co-Funded Studies for Innovative Medical Devices in Germany (§137e SGB V)”, a coverage with evidence development program in hospital and ambulatory sectors. The Paper explains strategic rationale, legal framework, procedural steps required to launch a co-funded study and data about the utilization of the scheme.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its EU HTA Publications Digest. In a recent publication, Ivo et al. examined the evolution and future prospects of European-level cooperation in health technology assessment, focusing on the implementation of the EU HTA Regulation. The authors highlighted the critical role of harmonised methodologies and coordinated capacity building in overcoming national heterogeneity. The new regulation is expected to streamline assessments, improve efficiency, and accelerate equitable access to innovative health technologies across Europe.

On June 6, 2025, NHS England published an updated work plan for the development of Clinical Commissioning Policies for specialised services. Two new MedTech-related policies concerning interventional radiology were added to the work program, and none have been published since the previous update. The status of ongoing policies has also been updated.

On June 10, 2025, the Swiss Federal Office of Public Health published updates to the Healthcare Benefit Ordinance (KLV/OPre), which determines coverage of medical services in Switzerland. The changes will take effect on July 1, 2025, and relate to colorectal cancer screening with the increase in the number of reimbursed colonoscopies, cancer treatment, men’s health, medical aids, and other medical services.